Skip to main
PBLS

Parabilis Medicines Inc. (PBLS)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy PBLS Stock

About Parabilis Medicines Inc. (PBLS)

Parabilis Medicines Inc.
Market cap$89.27M
Yesterday's volume1.04M
Revenue (TTM)
Avg. daily volume2.04M
EBITDA (TTM)
Open$29.86
Price / earnings ratio
Yesterday's range$26.88 - $32.47
Debt / equity0.22x
52 week range$20 - $34.47
5 year debt / equity-0.64x
Beta (LTM)-14.92x
Interest coverage-99.92x
Dividend & yield$0.00 (0.00%)
Current ratio6.12x
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 12, 2026, the market cap for PBLS stock is $89.28M

The 52-week high for PBLS stock is $34.47. The current PBLS stock price $undefined is 100.00% below its 52-week high

The 52-week low for PBLS stock is $20. The current PBLS stock price $undefined has increased 100.00% from its 52-week low

No, the PBLS stock does not pay dividends to its shareholders

How to buy PBLS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PBLS stock

    Navigate to the Explore page. Then, type PBLS into the search bar. When you see PBLS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PBLS stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

Buy PBLS Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.